Clinical Trial Update: Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating low dose decitabine with tirelizumab versus tirelizumab alone as first-line treatment for advanced esophageal squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Decitabine (Decitabine)
• Tirelizumab (tirelizumab)

Snippet

Sponsor: Fudan University | Conditions: PFS | Phase 2 | Status: UNKNOWN